L Schramm
Overview
Explore the profile of L Schramm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dziuba M, Paulus A, Schramm L, Awal R, Posfai M, Monteil C, et al.
ISME J
. 2022 Dec;
17(3):326-339.
PMID: 36517527
Horizontal gene transfer is a powerful source of innovations in prokaryotes that can affect almost any cellular system, including microbial organelles. The formation of magnetosomes, one of the most sophisticated...
2.
Diette N, Koo J, Cabarcas-Petroski S, Schramm L
J Carcinog Mutagen
. 2016 May;
7(1).
PMID: 27158556
Background: RNA polymerase (pol) III transcribes a variety of untranslated RNAs responsible for regulating cellular growth and is deregulated in a variety of cancers. In this study, we examined gender...
3.
Keilhauer C, Gal A, Sold J, Zimmermann J, Netzer K, Schramm L
Klin Monbl Augenheilkd
. 2007 Mar;
224(3):207-9.
PMID: 17385124
The oculo-cerebro-renal syndrome of Lowe (OCRL) is a rare X-chromosomal disorder characterised by the triad of congenital cataracts, renal tubular dysfunction, and mental retardation. Typically complete opacification and discoid deformation...
4.
Schramm L, Weierich T, Heldbreder E, Zimmermann J, Netzer K, Wanner C
J Nephrol
. 2005 Oct;
18(4):374-81.
PMID: 16245240
Background: The regulation of renal hemodynamics is closely related to the L-arginine (L-Arg)/nitric oxide (NO) pathway. NO - metabolized from L-Arg - is capable of improving renal function in ischemic...
5.
Lopau K, Kleinert D, Erler J, Schramm L, HEIDBREDER E, Wanner C
Transpl Int
. 2001 Jan;
13(6):436-42.
PMID: 11140242
Nephrotoxicity is one of the main side effects of calcineurin-inhibitors. The influence of tacrolimus on the renal vasculature has not been well described. We have therefore examined the effects of...
6.
Lopau K, Mark J, Schramm L, HEIDBREDER E, Wanner C
Transpl Int
. 2000 Dec;
13 Suppl 1:S282-5.
PMID: 11112013
Kidneys obtained from brain dead donors show inferior graft survival compared to living donation. The effects of brain death itself are thought to be partly responsible for these results. We,...
7.
Schramm L, Pendergrast P, Sun Y, Hernandez N
Genes Dev
. 2000 Oct;
14(20):2650-63.
PMID: 11040218
Transcription initiation at RNA polymerase III promoters requires transcription factor IIIB (TFIIIB), an activity that binds to RNA polymerase III promoters, generally through protein-protein contacts with DNA binding factors, and...
8.
Verschuuren J, Dalmau J, Tunkel R, Lang B, Graus F, Schramm L, et al.
Neurology
. 1998 Mar;
50(2):475-9.
PMID: 9484375
The sera of patients with Lambert-Eaton myasthenic syndrome (LEMS) contain autoantibodies against several extracellular and intracellular components of the voltage-gated calcium channel (VGCC)/synaptic vesicle release complex. An example of the...
9.
Rosenfeld M, Bergman I, Schramm L, Griffin J, Kaplitt M, Meneses P
J Neurooncol
. 1997 Sep;
34(2):139-44.
PMID: 9210060
Leptomeningeal carcinomatosis is a painful and debilitating complication of cancer. Indwelling reservoirs provide continuous assess to the subarachnoid space, making leptomeningeal cancer potentially amenable to gene therapy. Adeno-associated virus (AAV)...
10.
Rosenfeld M, Malats N, Schramm L, Graus F, Cardenal F, Vinolas N, et al.
J Natl Cancer Inst
. 1997 Mar;
89(5):381-5.
PMID: 9060960
Background: Some patients with cancer develop antibodies against the p53 tumor suppressor protein. The presence of these antibodies in serum has been associated with the expression of mutant p53 by...